Oragenics
OGEN | AMEX
$0.49
-$0.01 (-2.58%)
At close: Sep 25, 2026, 4:00 PM ET
-2.58%
(1D)Rating
Key Statistics
Market Data
Market Cap $2.2M
1D Range
0.48 0.52
52W Range
0.48 1.45
Valuation (TTM)
PE -0.14
PB 0.60
EV/EBITDA 0.23
Valuation (NTM)
Forward PE N/A
Forward PEG 0.02
Price Target N/A
Cash Flow
FCF Yield -463.8%
SBC Adj. FCF Yield -468.8%
SBC Impact -1.1%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 28.1% |
11.9%
FCF 3Y | 5Y -18.1% |
13.9%
Returns
ROA -183.6%
ROE -144.2%
ROIC -279.5%
Financial Health
Net Cash
$3.86M
Current Ratio 3.01
Interest Coverage -561.90
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the ...
Sector Healthcare
Industry Biotechnology
Employees 3
IPO Date Feb 25, 2004
Website www.oragenics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove OGEN